Several studies have shown that a considerable proportion of patients with fatty liver have ALT levels below the laboratory-set upper limit, especially in some NAFLD patients with advanced histological damage (53, 55, 61), who require more attention. The gene discussed is GPT; the disease is fatty liver disease.